Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
STAMFORD, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively …